{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:03:16Z","timestamp":1790697796423,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The aim of this study was to develop an overall survival (OS) prediction model integrating key somatic driver gene mutations in patients with pancreatic ductal adenocarcinoma (PDAC) undergoing curative-intent pancreatectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with resected PDAC from a prospectively maintained pancreatectomy database from 2018 to 2023 were identified. Somatic mutations in KRAS, TP53, SMAD4, and CDKN2A were assessed using in-house or commercial sequencing panels. Restricted cubic spline analyses were used to assess non-linear effects. An integrated Cox proportional hazards model incorporating genomic and clinicopathological variables was developed to predict OS and validated using 1000 bootstrap resamples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 885 patients were identified, of whom 663 met the inclusion criteria. After a median follow-up of 40.8\u2005months, 387 deaths occurred (median OS of 28.4\u2005months). The 1-, 2-, and 3-year OS rates were 80.0%, 56.2%, and 41.5% respectively. In univariable analysis, mutations in KRAS, TP53, SMAD4, and CDKN2A were each associated with inferior OS. Mortality risk increased with the cumulative number of mutated driver genes and remained independently significant in multivariable analysis (0\u20134; HR per mutation 1.27; P &amp;lt; 0.001). Other independent OS predictors included advanced age, resectability status, elevated pretreatment carbohydrate antigen 19-9 (CA19-9), larger tumour size, positive nodal stage, lymphovascular invasion, poor differentiation, neoadjuvant response classification, and receipt of adjuvant chemotherapy. The integrated model showed moderate discrimination (C-index 0.690 (95% c.i. 0.669 to 0.723); optimism-corrected C-index 0.676), which was significantly higher than AJCC eighth edition pathological staging alone (C-index 0.568 (95% c.i. 0.545 to 0.599); \u0394C = 0.122; P &amp;lt; 0.001), with reasonable calibration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The cumulative burden of driver gene mutations provided independent and incremental prognostic information after PDAC resection. External validation is required before clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjs\/znag123","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:51:28Z","timestamp":1788954688000},"source":"Crossref","is-referenced-by-count":0,"title":["Integrated driver gene-based survival prediction in resected pancreatic cancer"],"prefix":"10.1093","volume":"113","author":[{"given":"Zheng","family":"Li","sequence":"first","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]},{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Centre , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brady A","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Dal","family":"Molin","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"McPhaul","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L","family":"Cameron","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Tseh","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4554-5672","authenticated-orcid":false,"given":"Ralph H","family":"Hruban","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R","family":"Shubert","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7070-7269","authenticated-orcid":false,"given":"Kelly J","family":"Lafaro","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1087-0870","authenticated-orcid":false,"given":"Richard A","family":"Burkhart","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R","family":"Burns","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9149-2247","authenticated-orcid":false,"given":"Jin","family":"He","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"2026092911181376800_znag123-B1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026092911181376800_znag123-B2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"2026092911181376800_znag123-B3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","article-title":"Integrated genomic characterization of pancreatic ductal adenocarcinoma","volume":"32","author":"Raphael","year":"2017","journal-title":"Cancer Cell"},{"key":"2026092911181376800_znag123-B4","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","article-title":"Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma","volume":"267","author":"Groot","year":"2018","journal-title":"Ann Surg"},{"key":"2026092911181376800_znag123-B5","volume-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"2026092911181376800_znag123-B6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"key":"2026092911181376800_znag123-B7","doi-asserted-by":"crossref","first-page":"e173420","DOI":"10.1001\/jamaoncol.2017.3420","article-title":"Association of alterations in main driver genes with outcomes of patients with resected pancreatic ductal adenocarcinoma","volume":"4","author":"Qian","year":"2018","journal-title":"JAMA Oncol"},{"key":"2026092911181376800_znag123-B8","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1002\/cncr.33038","article-title":"Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma","volume":"126","author":"McIntyre","year":"2020","journal-title":"Cancer"},{"key":"2026092911181376800_znag123-B9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/SLA.0000000000006794","article-title":"The mutational status of driver genes in patients with resected pancreatic ductal adenocarcinoma is associated with pathological characteristics and overall survival","volume":"282","author":"Campbell","year":"2025","journal-title":"Ann Surg"},{"key":"2026092911181376800_znag123-B10","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1245\/s10434-021-11081-z","article-title":"Comprehensive analysis of somatic mutations in driver genes of resected pancreatic ductal adenocarcinoma reveals KRAS G12D and mutant TP53 combination as an independent predictor of clinical outcome","volume":"29","author":"Shoucair","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"2026092911181376800_znag123-B11","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"2026092911181376800_znag123-B12","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1007\/s11605-021-05078-y","article-title":"Reliable detection of somatic mutations for pancreatic cancer in endoscopic ultrasonography-guided fine needle aspirates with next-generation sequencing: implications from a prospective cohort study","volume":"25","author":"Habib","year":"2021","journal-title":"J Gastrointest Surg"},{"key":"2026092911181376800_znag123-B13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","article-title":"Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Tempero","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"2026092911181376800_znag123-B14","first-page":"1129","article-title":"Protocol for the examination of specimens removed from patients with carcinoma of the exocrine pancreas: a basis for checklists. Cancer Committee, College of American Pathologists","volume":"121","author":"Compton","year":"1997","journal-title":"Arch Pathol Lab Med"},{"key":"2026092911181376800_znag123-B15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"2026092911181376800_znag123-B16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/sim.6370","article-title":"Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach","volume":"34","author":"Kang","year":"2015","journal-title":"Stat Med"},{"key":"2026092911181376800_znag123-B17","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006966","article-title":"SMAD4 alterations are a predictive biomarker to guide first-line chemotherapy selection for the neoadjuvant treatment of localized pancreatic cancer: a multicenter, retrospective cohort study","author":"Button","year":"2025","journal-title":"Ann Surg"},{"key":"2026092911181376800_znag123-B18","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1158\/1078-0432.CCR-09-0227","article-title":"SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer","volume":"15","author":"Blackford","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2026092911181376800_znag123-B19","doi-asserted-by":"crossref","first-page":"e2400684","DOI":"10.1200\/PO-24-00684","article-title":"Evaluating the effect of KRAS variants on survival outcomes and therapy response in pancreatic cancer","volume":"9","author":"Ebia","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"2026092911181376800_znag123-B20","doi-asserted-by":"crossref","first-page":"e2453588","DOI":"10.1001\/jamanetworkopen.2024.53588","article-title":"KRAS mutation status and treatment outcomes in patients with metastatic pancreatic adenocarcinoma","volume":"8","author":"Norton","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026092911181376800_znag123-B21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"Biankin","year":"2012","journal-title":"Nature"},{"key":"2026092911181376800_znag123-B22","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/PAI.0000000000000684","article-title":"Improved tumor purity metrics in next-generation sequencing for clinical practice. The integrated interpretation of neoplastic cellularity and sequencing results (IINCaSe) approach","volume":"27","author":"Patel","year":"2019","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2026092911181376800_znag123-B23","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3390\/cancers7030859","article-title":"Analysis of pre-analytic factors affecting the success of clinical next-generation sequencing of solid organ malignancies","volume":"7","author":"Chen","year":"2015","journal-title":"Cancers (Basel)"},{"key":"2026092911181376800_znag123-B24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.anndiagpath.2018.10.013","article-title":"Measured residual tumor cellularity correlates with survival in neoadjuvant treated pancreatic ductal adenocarcinomas","volume":"38","author":"Rowan","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"2026092911181376800_znag123-B25","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1158\/1078-0432.CCR-17-3099","article-title":"Evaluating mismatch repair deficiency in pancreatic adenocarcinoma: challenges and recommendations","volume":"24","author":"Hu","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2026092911181376800_znag123-B26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/gutjnl-2020-320726","article-title":"Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications","volume":"70","author":"Luchini","year":"2021","journal-title":"Gut"},{"key":"2026092911181376800_znag123-B27","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.ejso.2019.05.031","article-title":"Postoperative surveillance of pancreatic cancer patients","volume":"45","author":"Daamen","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"2026092911181376800_znag123-B28","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1200\/JCO.22.02668","article-title":"Prediction of adjuvant gemcitabine sensitivity in resectable pancreatic adenocarcinoma using the GemPred RNA signature: an ancillary study of the PRODIGE-24\/CCTG PA6 clinical trial","volume":"42","author":"Nicolle","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026092911181376800_znag123-B29","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1158\/1078-0432.CCR-12-1215","article-title":"Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors","volume":"18","author":"Yachida","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2026092911181376800_znag123-B30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng0994-27","article-title":"Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma","volume":"8","author":"Caldas","year":"1994","journal-title":"Nat Genet"}],"container-title":["British Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/113\/9\/znag123\/71466062\/znag123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/113\/9\/znag123\/71466062\/znag123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:18:21Z","timestamp":1790695101000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/doi\/10.1093\/bjs\/znag123\/8845529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,29]]},"published-print":{"date-parts":[[2026,8,27]]}},"URL":"https:\/\/doi.org\/10.1093\/bjs\/znag123","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,27]]},"article-number":"znag123"}}